NADI Virtual Seminar "Diabetes and the Heart"

DAY 1 – 15 JANUARY 2022 (SATURDAY)

0745 - 0825         

REGISTRATION

0825 - 0830

Welcome Message

0830 - 0930

Session #1: HEART DISEASES IN DIABETICS

i)         Screening for HD in Diabetics: When & How (20 min)

ii)        Management of Diabetes in Patients with Heart Disease (20 min)

iii)       Q & A session (20 min)

0930 - 1000

Sponsored lecture #1 (20 min + 10 min Q&A)

1000 - 1030

Sponsored lecture #2 (20 min + 10 min Q&A)

1030 - 1100

BREAK (Visit Virtual Booths)

1100 - 1230

Case Discussions

Case #1: Sponsored #1 Case Discussion   

                (15 min +15 min discussion)

Case #2: Sponsored #2 Case Discussion   

                 (15 min +15 min discussion)

Case #3: NADI Case Discussion: Diabetic with Suspected IHD 

                 (10 min +20 min discussion)

1230 - 1330

LUNCH BREAK

1330 - 1500

Session #2: GLP1-RAS UPDATES

i)            The Story of GLP1-RA: from Gila Monster to the Bedside (20 Min)

ii)           Clinical trials of GLP1-RAs in Diabetics (20 Min)

iii)         Choosing GLP1-RA for Diabetics: Practical Considerations (20 Min)

iv)          Q & A session (30 min)

1500 - 1530

Sponsored Lecture #3 (20 min + 10 min Q&A)

1530 - 1600

BREAK (Signing CPD & Visit Virtual Booths)

1600 - 1700

Case Discussions

Case #4: Sponsored #3 Case Discussion   

                (15 min +15 min discussion)

Case #5: NADI Case Discussion: Diabetic Recovering from MI

                (10 min + 20 min discussion)

1700 - 1800

Session #3: HYPERTENSION IN DIABETICS            

i)    Current Evidence-Based BP Targets (20 Min)            

ii)   Which Drug(S) for BP Control in Patients with Diabetes? (20 Min)

iii) Q & A (20 Min)

1800

END OF DAY 1

DAY 2 - 16 JANUARY 2022 (SUNDAY)

0800 - 0830         

REGISTRATION

0830 - 0930

Session #4: HEART FAILURE IN DIABETICS

i)         Assessing HF Risk in Diabetics (20 Min)

ii)        Managing HF: Recent Advances (20 Min)

iii)       Q & A session (20 Min)

0930 - 1000

Sponsored Lecture #4 (20 min + 10 min Q&A)

1000 - 1030

Sponsored Lecture #5 (20 min + 10 min Q&A)

1030 - 1100

BREAK (Visit Virtual Booths)

1100 - 1230

Case Discussions

Case #6: Sponsored #4 Case Discussion   

                (15 min +15 min discussion)

Case #7: Sponsored #5 Case Discussion   

                (15 min +15 min discussion)

Case #8: NADI Case Discussion:

                        Patient Presented with SOB and Ankle Oedema

                (10 min + 20 min discussion)

1230 - 1330

LUNCH BREAK

1330 - 1430

Session #5: UPDATES ON SGLT2 -INHIBITORS

i)         Landmark Clinical Trials of SGLT2-I in Diabetics (20 Min)

ii)        Mechanisms of CV benefits of SGLT2-Inhibitors (20 Min)

iii)       Q & A (20 Min)

1430 - 1500

Sponsored Lecture #6 (20 min + 10 min Q&A)

1500 - 1530

BREAK (Signing CPD & Visit Virtual Booths)

1530 - 1600

Advances in the Management of Peripheral Vascular Disease in Diabetics     

(20 min +10 min Q&A)

1600 - 1700

Case Discussions

Case #9: Sponsored #6 Case Discussion   

                (15 min +15 min discussion)

Case #10: NADI Case Discussion   

                 (10 min + 20 min discussion)

1700 - 1800

Session #6: Diabetic Dyslipidaemia

i)         Pattern (and Assessment) of Dyslipidaemia in Diabetics (20 Min)

ii)        Managing Diabetic Dyslipidaemia to Prevent Heart Disease (20 Min)

iii)       Q & A (20 Min)

1800

END OF SEMINAR